Advertisement

Topics

Allergy Therapeutics Company Profile

20:28 EDT 19th September 2017 | BioPortfolio

Allergy Therapeutics®. (AT) is a Europe-based specialty pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19m/€27m per annum, an MHRA-approved manufacturing capability and an established sales and marketing infrastructure in several major European markets. In addition, the Company has a number of novel compounds which have already undergone initial clinical evaluation and once registered could potentially revolutionise the treatment of allergy. An established range of specific immunotherapy diagnostics and therapies, generating growing revenues of approximately £19m/€27m per annum.
Certain exclusive rights to MPL®, a novel immunological adjuvant in the field of allergy, licensed from Corixa Corporation.
An innovative product development pipeline supported by documented clinical evidence of efficacy and safety.
Intellectual property rights to five patent families with further rights to the use of MPL® in new formulations. Patent protection for new products extends to the years 2018-20.
A highly qualified scientific and commercial team with industry experienced management.
A European sales and marketing team in Germany, Italy and Spain.
High quality facilities, including cGMP manufacturing, capable of increased production capacity.

Location

Dominion Way
Worthing
West Sussex
BN14 8SA
United Kingdom

Contact

Phone: 44 1903 844700
Fax: 44 1903 844744
Email: infoservices@allergytherapeutics.com


News Articles [1929 Associated News Articles listed on BioPortfolio]

Allergy Therapeutics eyes 15% sales jump

UK group Allergy Therapeutics has announced that its sales for the year are on track to overshoot market expectations at £64.1 million, as its hay fever vaccines continue to gain ground in core Europ...

Allergy Therapeutics Aktie // Wo der Brexit keinen Heuschnupfen bekommt

Immer mehr Menschen leiden unter Allergien. Die britische Allergy Therapeutics ist in diesem Geschäft einer der großen Anbieter in Deutschland. Viel Rückendwind bekommt das Pharmaunternehmen aber a...

Aimmune Therapeutics to Present Data on Peanut Allergy in Europe at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2017

Thursday, June 15th 2017 at 12:00pm UTC — Abstracts Report on Screening Population for PALISADE Phase 3 Clinical Trial and Current Management of Peanut Allergy — BRISBANE, California–(BUSINE...

British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial

Allergy Therapeutics’ vaccine against hayfever has received approval to begin a trial to determine its optimal dose. Allergy Therapeutics will begin a Phase II trial of its PQ Grass vaccine for ...

Allergy Therapeutics publishes pre-clinical data on malaria and flu vaccines

Allergy Therapeutics (LON:AGY) has published data in peer-reviewed journals from two preclinical studies analysing its immuno-therapy platform as a potential vaccine against malaria and the flu. ...

Aimmune Therapeutics to Present Data on Peanut Allergy in Europe at the European Academy of ...

— Abstracts Report on Screening Population for PALISADE Phase 3 Clinical Trial and Current Management of Peanut Allergy — Read more...

Medical News Today: Potato allergy: Risk factors and symptoms

What causes a potato allergy and who gets a potato allergy? Learn about the complications caused by the allergy and what foods should be avoided.

Aimmune to make peanut allergy candidate in Florida, US

Aimmune Therapeutics has opened its commercial manufacturing facility in Florida, US, where it will manufacture its investigational peanut allergy treatment.

PubMed Articles [1211 Associated PubMed Articles listed on BioPortfolio]

Association between Caesarean Delivery and Isolated Doses of Formula Feeding in Cow Milk Allergy.

Cow milk allergy (CMA) is the most common food allergy in breastfed infants. The aim of this study is to verify whether certain perinatal factors may influence the development of CMA immunoglobulin E ...

Contact Allergy to Topical Mometasone Furoate Confirmed by Rechallenge and Patch Test.

The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.

In terms of immune regulating functions, analysis of the microbiome has led the development of therapeutic strategies that may be applicable to asthma management. This review summarizes the current li...

The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Antibiotic allergy labeling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engageme...

CXCL4 is a novel nickel-binding protein and augments nickel allergy.

Nickel (Ni) is the most frequent metal allergen and induces a TH1 -dependent type-IV allergy. Although Ni(2+) is considered to bind to endogenous proteins, it currently remains unclear whether these N...

Clinical Trials [520 Associated Clinical Trials listed on BioPortfolio]

The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy

Cow's milk protein (CMP) allergy is one of the most common food allergies and potentially a fatal one. Early feeding with CMP has been considered in the past as a risk factor for developme...

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

The purpose of this research study is to find out if cat allergy shots with combination with AMG 157, an experimental medication, will help the cat allergy shots work after just one year o...

Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects

Cat allergy is an increasingly prevalent condition, affecting 10-15% of patients with allergic rhinoconjunctivitis and/or asthma. Cat-PAD is a novel, synthetic, allergen-derived peptide d...

Sublingual Milk Immunotherapy in Children

Sublingual immunotherapy is developing in the treatment of aeroallergens allergy. The hypothesis is that such process may be applied to food allergy, more precisely to milk. A previous se...

Basophil Activation Test (BAT) Sensitivity in Child Food Allergy

Child food allergy represent 6 to 8% of child in industrialised country. Within this allergy, peanuts and egg allergy are one of the most common. Actually when there is a suspicion of foo...

Companies [1294 Associated Companies listed on BioPortfolio]

Allergy Cure

Allergies like food allergies i.e. Peanut allergy wheat allergy milk allergy dog allergies cat allergies latex allergy skin allergies dust mites allergy cure by Aller-X herbal Medicine admark herba...

Prota Therapeutics Pty Ltd

Prota Therapeutics is a newly established Australian private company developing immunotherapy based treatments for food allergy. The company’s lead product based on innovativ...

HAL Allergy Group

The HAL Allergy Group (http://www.hal-allergy.com) was established in 1959 and is a main European manufacturer of allergy vaccines and diagnostics. The Group's products are distributed via subsidi...

Planet Technologies

On March 9, 2005, Planet announced a definitive agreement to acquire privately-owned Allergy Control Products. The combination of Planet’s Allergy Free business with Allergy Control will create one ...

Allergy Therapeutics

Allergy Therapeutics®. (AT) is a Europe-based specialty pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19m/€27m per an...

More Information about "Allergy Therapeutics" on BioPortfolio

We have published hundreds of Allergy Therapeutics news stories on BioPortfolio along with dozens of Allergy Therapeutics Clinical Trials and PubMed Articles about Allergy Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergy Therapeutics Companies in our database. You can also find out about relevant Allergy Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record